Amgen

Forecast & Rating34 analysts currently cover Amgen, with about 35.3% giving a positive rating — meaning they expect the stock to rise. The average price target is $390.94, about 7.3% downside from the current price of $421.51. Price targets range from $225.00 to $500.00 — a wide spread, showing clear disagreement over just how much Amgen can rise. Historically, about 92.2% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Amgen's outlook. Data as of Sep 30, 2026; for reference only and not investment advice.